Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Dermatology

Journal Scan / Research · December 29, 2021

Efficacy and Safety of Ustekinumab in Behçet's Disease

Journal of the American Academy of Dermatology

 

Additional Info

Journal of the American Academy of Dermatology
Efficacy and safety of ustekinumab in Behçet disease: Results from the prospective phase 2 STELABEC trial
J Am Acad Dermatol 2021 Dec 02;[EPub Ahead of Print], J London, A Régent, J Dion, L Jilet, M Jachiet, O Lidove, F Cohen-Aubart, S Aractingi, S Guégan, JL Pennaforte, H Abdoul, X Puéchal, B Terrier

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading